Education
About Us
Working with TipRanks
Follow Us
Solesence, Inc (SLSN)
:SLSN
SLSN Stock Chart & Stats
$2.17
--
Market closed
$2.17
--
Day’s Range― - ―
52-Week Range$1.34 - $16.56
Previous CloseN/A
VolumeN/A
Average Volume (3M)50.44K
Market Cap
$143.54M
Enterprise Value$251.77M
Total Cash (Recent Filing)$429.00K
Total Debt (Recent Filing)$25.18M
Price to Earnings (P/E)145.4
Beta1.32
Next Earnings
Apr 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding70,536,840
10 Day Avg. Volume43,263
30 Day Avg. Volume50,441
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)10.18
Price to Sales (P/S)2.91
P/FCF Ratio-58.81
Enterprise Value/Market Cap1.75
Enterprise Value/Revenue4.05
Enterprise Value/Gross Profit16.35
Enterprise Value/Ebitda76.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Solesence News
SLSN FAQ
What was Solesence, Inc’s price range in the past 12 months?
Solesence, Inc lowest stock price was $1.34 and its highest was $16.56 in the past 12 months.
What is Solesence, Inc’s market cap?
Solesence, Inc’s market cap is $143.54M.
When is Solesence, Inc’s upcoming earnings report date?
Solesence, Inc’s upcoming earnings report date is Apr 01, 2026 which is in 102 days.
How were Solesence, Inc’s earnings last quarter?
Solesence, Inc released its earnings results on Nov 11, 2025. The company reported -$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.016.
Is Solesence, Inc overvalued?
According to Wall Street analysts Solesence, Inc’s price is currently Overvalued.
Does Solesence, Inc pay dividends?
Solesence, Inc does not currently pay dividends.
What is Solesence, Inc’s EPS estimate?
Solesence, Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solesence, Inc have?
Solesence, Inc has 70,536,840 shares outstanding.
What happened to Solesence, Inc’s price movement after its last earnings report?
Solesence, Inc reported an EPS of -$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -24.199%.
Which hedge fund is a major shareholder of Solesence, Inc?
Currently, no hedge funds are holding shares in SLSN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Solesence Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.30%
12-Months-Change
Fundamentals
Return on Equity
6.60%
Trailing 12-Months
Asset Growth
12.36%
Trailing 12-Months
Company Description
Solesence, Inc
Solesence (SLSN) is a biotechnology company focused on developing innovative solutions for the cosmetics and personal care industries. The company specializes in harnessing the power of natural ingredients to create advanced formulations that enhance the performance and sensory attributes of beauty products. With a strong emphasis on sustainability and efficacy, Solesence serves a diverse range of clients, including leading beauty brands and manufacturers, by providing proprietary technology and products that improve product stability, texture, and delivery of active ingredients.
SLSN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging quarter with a notable decline in revenue and profitability. However, the company highlights strategic operational improvements and leadership changes aimed at driving future growth. Although the short-term financials are negative, there is optimism about long-term growth and market leadership.View all SLSN earnings summariesTechnical Analysis
Helen Of Troy
―
Nu Skin
―
Edgewell Personal Care
―
Beauty Health
―
European Wax Center
―
Ownership Overview
77.34% Insiders
2.01% Mutual Funds
0.10% Other Institutional Investors
18.42% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---